Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Autoinjectors for Administering Glatiramer Acetate in Relapsing Remitting Multiple Sclerosis in Europe: A Survey of Patient and Nurse Preferences
Saved in:
| Published in: | Degenerative Neurological and Neuromuscular Disease |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2024
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Autoinjectors for Administering Glatiramer Acetate in Relapsing Remitting Multiple Sclerosis in Europe: A Survey of Patient and Nurse Preferences
- A Qualitative Study of Lived Treatment Experiences and Preferences of Long-Term DMT Users with Relapsing–Remitting Multiple Sclerosis
- Correction: Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two‑year Phase IV CLARIFY‑MS Study
- Social Cognition in Multiple Sclerosis: A Multidomain Investigation
- Human herpesvirus 6A and other risk factors for multiple sclerosis
- Understanding Routine Treatment and Resource Availability for Fatigue in Multiple Sclerosis in the United Kingdom
- Integrated Transcriptome Analysis Reveals Molecular Subtypes and ceRNA Networks in Multiple Sclerosis